Quick Answer
CNBX Pharmaceuticals Inc. reported Common Stock Shares Outstanding of 553.96 million shares for the year ending 2025.
- CNBX Pharmaceuticals Inc. showed an increase of +1,680.6% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from CNBX Pharmaceuticals Inc.'s annual report (Form 10-K), filed with the SEC on December 1, 2025.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2014: 81.76 million shares | Q4 2014: 100.63 million shares | Q1 2015: 100.63 million shares | Q2 2015: 100.72 million shares | Q4 2015: 102.15 million shares | Q1 2016: 102.65 million shares | Q2 2016: 107.03 million shares | Q4 2016: 114.08 million shares | Q1 2017: 114.68 million shares | Q2 2017: 118.32 million shares | Q4 2017: 119.56 million shares | Q1 2018: 120.49 million shares | Q2 2018: 120.82 million shares | Q4 2018: 131.83 million shares | Q1 2019: 132.19 million shares | Q2 2019: 134.46 million shares | Q4 2019: 134.42 million shares | Q1 2020: 135.04 million shares | Q2 2020: 135.08 million shares | Q4 2020: 135.24 million shares | Q1 2021: 135.24 million shares | Q2 2021: 142.58 million shares | Q4 2021: 148.66 million shares | Q1 2022: 149.44 million shares | Q2 2022: 1.24 million shares | Q4 2022: 1.26 million shares | Q1 2023: 2.21 million shares | Q2 2023: 16.03 million shares | Q4 2023: 28.31 million shares | Q1 2024: 3.11 million shares | Q2 2024: 3.11 million shares | Q4 2024: 31.11 million shares | Q1 2025: 33.86 million shares | Q2 2025: 92.51 million shares | Q3 2025: 553.96 million shares | Q4 2025: 753.20 million shares.
- Over the full 13 years of available data (2013 to 2025), CNBX Pharmaceuticals Inc.'s Common Stock Shares Outstanding has grown by 40,620.4%.
- Historical annual values: Fiscal year 2025: 553.96 million shares | Fiscal year 2024: 31.11 million shares | Fiscal year 2023: 22.61 million shares | Fiscal year 2022: 1.24 million shares | Fiscal year 2021: 148.66 million shares | Fiscal year 2020: 135.08 million shares | Fiscal year 2019: 134.50 million shares | Fiscal year 2018: 121.58 million shares | Fiscal year 2017: 119.54 million shares | Fiscal year 2016: 107.22 million shares | Fiscal year 2015: 101.50 million shares | Fiscal year 2014: 100.25 million shares | Fiscal year 2013: 1.36 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: